Messroghli, DR;
Moon, JC;
Ferreira, VM;
Grosse-Wortmann, L;
He, T;
Kellman, P;
Mascherbauer, J;
Nezafat, R;
Salerno, M;
Schelbert, EB;
et al.
Messroghli, DR; Moon, JC; Ferreira, VM; Grosse-Wortmann, L; He, T; Kellman, P; Mascherbauer, J; Nezafat, R; Salerno, M; Schelbert, EB; Taylor, AJ; Thompson, R; Ugander, M; van Heeswijk, RB; Friedrich, MG
(2017)
Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI).
J Cardiovasc Magn Reson, 19 (1).
p. 75.
ISSN 1532-429X
https://doi.org/10.1186/s12968-017-0389-8
SGUL Authors: He, Taigang
|
PDF
Published Version
Available under License Creative Commons Attribution. Download (1MB) | Preview |
Abstract
Parametric mapping techniques provide a non-invasive tool for quantifying tissue alterations in myocardial disease in those eligible for cardiovascular magnetic resonance (CMR). Parametric mapping with CMR now permits the routine spatial visualization and quantification of changes in myocardial composition based on changes in T1, T2, and T2*(star) relaxation times and extracellular volume (ECV). These changes include specific disease pathways related to mainly intracellular disturbances of the cardiomyocyte (e.g., iron overload, or glycosphingolipid accumulation in Anderson-Fabry disease); extracellular disturbances in the myocardial interstitium (e.g., myocardial fibrosis or cardiac amyloidosis from accumulation of collagen or amyloid proteins, respectively); or both (myocardial edema with increased intracellular and/or extracellular water). Parametric mapping promises improvements in patient care through advances in quantitative diagnostics, inter- and intra-patient comparability, and relatedly improvements in treatment. There is a multitude of technical approaches and potential applications. This document provides a summary of the existing evidence for the clinical value of parametric mapping in the heart as of mid 2017, and gives recommendations for practical use in different clinical scenarios for scientists, clinicians, and CMR manufacturers.
Item Type: | Article | ||||||
---|---|---|---|---|---|---|---|
Additional Information: | Correction available at https://doi.org/10.1186/s12968-017-0408-9 © The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. | ||||||
Keywords: | Nuclear Medicine & Medical Imaging, 1102 Cardiovascular Medicine And Haematology | ||||||
SGUL Research Institute / Research Centre: | Academic Structure > Molecular and Clinical Sciences Research Institute (MCS) Academic Structure > Molecular and Clinical Sciences Research Institute (MCS) > Cardiac (INCCCA) |
||||||
Journal or Publication Title: | J Cardiovasc Magn Reson | ||||||
ISSN: | 1532-429X | ||||||
Language: | eng | ||||||
Dates: |
|
||||||
Publisher License: | Creative Commons: Attribution 4.0 | ||||||
PubMed ID: | 28992817 | ||||||
Go to PubMed abstract | |||||||
URI: | https://openaccess.sgul.ac.uk/id/eprint/109219 | ||||||
Publisher's version: | https://doi.org/10.1186/s12968-017-0389-8 |
Statistics
Actions (login required)
![]() |
Edit Item |